Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Oneness Biotech Co., Ltd., a Taiwan-based biotechnology company advancing innovative drugs for metabolic disorders, today announced completion of the single-ascending dose (SAD) portion (Part A) in healthy volunteers of its ongoing Phase 1 clinical trial evaluating SNS851 as a potential treatment f…
The Taiwan-based biotech said it completed the single-ascending dose portion of its phase 1 trial for SNS851 in healthy volunteers and is moving to multiple-ascending dose testing in participants with fatty liver disease. Data from the MAD portion are expected in Q1 2027.